Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Liver Int. 2020 May 2;40(7):1693–1700. doi: 10.1111/liv.14474

Table 2:

miRNAs that change over time in the entire cohort

miRNAs Decreased with Treatment miRNAs Increased with Treatment
miRNA Spearman rho P-value miRNA Spearman rho P-value
34a-5p −0.62 4.6 × 10−7 374a-5p 0.31 3.4 × 10−2
885-5p −0.53 1.8 × 10−5 423-5p 0.31 3.2 × 10−2
122-5p −0.47 3.4 × 10−4 106b-5p 0.32 2.7 × 10−2
215-5p −0.45 5.6 × 10−4 363-3p 0.32 2.9 × 10−2
148a-3p −0.44 9.7 × 10−4 140-5p 0.35 1.2 × 10−2
100-5p −0.42 1.5 × 10−3 18a-5p 0.36 8.2 × 10−3
125b-5p −0.4 2.9 × 10−3 93-5p 0.39 3.8 × 10−3
192-5p −0.4 3.5 × 10−3 106a-5p 0.4 2.7 × 10−3
30a-5p −0.4 2.7 × 10−3
194-5p −0.38 5.6 × 10−3

Shown are miRNAs with significantly different expression at week 240 relative to week 0 considering all 28 patients.